TY - JOUR
T1 - Hepatitis C virus testing among men with human immunodeficiency virus who have sex with men
T2 - Temporal trends and racial/ethnic disparities
AU - Li, Jun
AU - Armon, Carl
AU - Palella, Frank J.
AU - Tedaldi, Ellen
AU - Novak, Richard M.
AU - Fuhrer, Jack
AU - Simoncini, Gina
AU - Carlson, Kimberly
AU - Buchacz, Kate
AU - Li, Jun
AU - Buchacz, Kate
AU - Durham, Marcus D.
AU - Akridge, Cheryl
AU - Purinton, Stacey
AU - Rayeed, Nabil
AU - Agbobil-Nuwoaty, Selom
AU - Chagaris, Kalliope
AU - Carlson, Kimberly
AU - Armon, Carl
AU - Battalora, Linda
AU - Mahnken, Jonathan
AU - Palella, Frank J.
AU - Jahangir, Saira
AU - Flaherty, Conor Daniel
AU - Bustamante, Patricia
AU - Hammer, John
AU - Greenberg, Kenneth S.
AU - Widick, Barbara
AU - Franklin, Rosa
AU - Ward, Douglas J.
AU - Thomas, Troy
AU - Stewart, Cheryl
AU - Fuhrer, Jack
AU - Ording-Bauer, Linda
AU - Kelly, Rita
AU - Esteves, Jane
AU - Tedaldi, Ellen M.
AU - Christian, Ramona A.
AU - Ruley, Faye
AU - Beadle, Dania
AU - Davenport, Princess
AU - Novak, Richard M.
AU - Wendrow, Andrea
AU - Mayer, Stockton
AU - Scott, Mia
AU - Thomas, Billie
AU - Van Slyke, Loraine
AU - Mayer, Cynthia
AU - Beitler, Terry
AU - Maroney, Karen
AU - Franklin, Denise
N1 - Publisher Copyright:
© 2021 Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background: National guidelines recommend that sexually active people with human immunodeficiency virus (PWH) who are men who have sex with men (MSM) be tested for hepatitis C virus (HCV) infection at least annually. Hepatitis C virus testing rates vary by race/ethnicity in the general population, but limited data are available for PWH. Methods: We analyzed medical records data from MSM in the HIV Outpatient Study at 9 human immunodeficiency virus (HIV) clinics from January 1, 2011 through December 31, 2019. We excluded observation time after documented past or current HCV infection. We evaluated HCV antibody testing in each calendar year among HCV-seronegative MSM, and we assessed testing correlates by generalized estimating equation analyses. Results: Of 1829 eligible MSM who were PWH, 1174 (64.2%) were non-Hispanic/Latino white (NHW), 402 (22.0%) non-Hispanic black (NHB), 187 (10.2%) Hispanic/Latino, and 66 (3.6%) of other race/ethnicity. Most were ≥40 years old (68.9%), privately insured (64.5%), with CD4 cell count/mm3 (CD4) ≥350 (77.0%), and with HIV viral load <200 copies/mL (76.9%). During 2011-2019, 1205 (65.9%) had ≥1 HCV antibody test and average annual HCV percentage tested was 30.3% (from 33.8% for NHB to 28.5% for NHW; P <. 001). Multivariable factors positively associated (P <. 05) with HCV testing included more recent HIV diagnosis, public insurance, lower CD4, prior chlamydia, gonorrhea, syphilis, or hepatitis B virus diagnoses, and elevated liver enzyme levels, but not race/ethnicity. Conclusions: Although we found no disparities by race/ethnicity in HCV testing, low overall HCV testing rates indicate suboptimal uptake of recommended HCV testing among MSM in HIV care.
AB - Background: National guidelines recommend that sexually active people with human immunodeficiency virus (PWH) who are men who have sex with men (MSM) be tested for hepatitis C virus (HCV) infection at least annually. Hepatitis C virus testing rates vary by race/ethnicity in the general population, but limited data are available for PWH. Methods: We analyzed medical records data from MSM in the HIV Outpatient Study at 9 human immunodeficiency virus (HIV) clinics from January 1, 2011 through December 31, 2019. We excluded observation time after documented past or current HCV infection. We evaluated HCV antibody testing in each calendar year among HCV-seronegative MSM, and we assessed testing correlates by generalized estimating equation analyses. Results: Of 1829 eligible MSM who were PWH, 1174 (64.2%) were non-Hispanic/Latino white (NHW), 402 (22.0%) non-Hispanic black (NHB), 187 (10.2%) Hispanic/Latino, and 66 (3.6%) of other race/ethnicity. Most were ≥40 years old (68.9%), privately insured (64.5%), with CD4 cell count/mm3 (CD4) ≥350 (77.0%), and with HIV viral load <200 copies/mL (76.9%). During 2011-2019, 1205 (65.9%) had ≥1 HCV antibody test and average annual HCV percentage tested was 30.3% (from 33.8% for NHB to 28.5% for NHW; P <. 001). Multivariable factors positively associated (P <. 05) with HCV testing included more recent HIV diagnosis, public insurance, lower CD4, prior chlamydia, gonorrhea, syphilis, or hepatitis B virus diagnoses, and elevated liver enzyme levels, but not race/ethnicity. Conclusions: Although we found no disparities by race/ethnicity in HCV testing, low overall HCV testing rates indicate suboptimal uptake of recommended HCV testing among MSM in HIV care.
KW - HCV testing
KW - HIV/AIDS
KW - epidemiology
KW - hepatitis
KW - treatment-naive
UR - http://www.scopus.com/inward/record.url?scp=85106400792&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106400792&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofaa645
DO - 10.1093/ofid/ofaa645
M3 - Article
C2 - 33889655
AN - SCOPUS:85106400792
SN - 2328-8957
VL - 8
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - 4
M1 - ofaa645
ER -